home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Factors Influencing Uptake of Genetic Testing For Colorectal Cancer Risk in an Australian Jewish Population

 
  October, 5 2005 9:21
your information resource in human molecular genetics
 
     
Factors Influencing Uptake of Genetic Testing For Colorectal Cancer Risk in an Australian Jewish Population

Authors:
B. J. Warner (1, 4) , L. J. Curnow (2), A. L. Polglase (1, 3) and H. S. Debinski (1)

Author Affiliations:
(1) Family Cancer Clinic, Cabrini Health, Melbourne, Australia
(2) Genetic Health Services of Victoria, Melbourne, Australia
(3) Monash University, Melbourne, Australia
(4) Family Cancer at Cabrini, Cabrini Hospital, 183 Wattletree Road, Malvern Victoria, 3144, Australia


There is a significant excess of colorectal cancer in the Australian Ashkenazi Jewish community. This study, published in the October 2005 issue of the Journal of Genetic Counseling (Vol. 14, No. 5, pp. 387-394), reports a high acceptability of genetic testing within a community sample of 300 Australian Jewish individuals — 94% of participants would have a test for predisposition to colorectal cancer and a majority would make this decision based on the desire for information for their families and to decrease their own cancer risk.

Author contact:

B. J. Warner
E-mail: bwarner@cabrini.com.au

Abstract available online.

(C) Journal of Genetic Counseling.

Posted by: Tressie Dalaya


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.